Trial · NCT06554028
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Laryngeal preservation rate at 3 months after radiotherapy | 3-month post-radiotherapy | defined as the absence of any residual disease that would justify salvage total laryngectomy |
| Secondary | Objective response rate after induction chemoimmunotherapy | 2 weeks after the end of cycle 3 of induction therapy | 2 weeks after the 3th cycle of induction therapy |
| Secondary | Overall survival rate at 1 year | One year post-radiotherapy | Overall survival rate at 1 year |
| Secondary | Laryngeal preservation rate at 1 year after radiotherapy | 1 year post-radiotherapy | defined as the absence of any residual disease that would justify salvage total laryngectomy |
| Secondary | Progression-free survival rate at 1 year | One year post-radiotherapy | Progression-free survival rate at 1 year |
| Secondary | Pathological complete response rate of the patients receiving surgical resection | Within 3 weeks after surgery | Pathological complete response rate of the patients receiving surgical resection, evaluated by experienced pathologists |
| Secondary | Overall survival rate at 2 year | Two year post-radiotherapy | Overall survival rate at 2 year |
| Secondary | Progression-free survival rate at 2 year | Two year post-radiotherapy | Progression-free survival rate at 2 year |
| Secondary | Laryngeal Preservation rate at 2 year | Laryngeal Preservation rate at 2 year | Two year post-radiotherapy |
| Secondary | Adverse Effect | One year post-radiotherapy | Adverse Effect, evaluated by CTCAE 4.0.03 |
| Secondary | Major pathologic response rate of the patients receiving surgical resection | Within 3 weeks after surgery | Major pathologic response rate, defined as no more than 10% of residual viable tumor, evaluated by experienced pathologists |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06554028/registered